Acorn Bioventures, L.P. Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity
Acorn Bioventures, L.P. is of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 1.71 Million shares of RPHM, which is worth approximately $2.87 Million. The most recent transaction as insider was on May 15, 2025, when has been sold 270,270 shares (Common Stock) at a price of $1.85 per share, resulting in proceeds of $499,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.71M
n/a
3M change
n/a
12M change
Total Value Held
$2.87 Million
ABL
Acorn Bioventures, L.P.
New York, NY